{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:10:57Z","timestamp":1740136257901,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-023-02532-2","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T11:04:33Z","timestamp":1680606273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Isolated abnormal FEF75% detects unsuspected bronchiolar obstruction in CF children"],"prefix":"10.1038","author":[{"given":"Vicki K.","family":"Masson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliezer","family":"Nussbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1664-6821","authenticated-orcid":false,"given":"Arthur F.","family":"Gelb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald P.","family":"Tashkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inderpal","family":"Randhawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay A.","family":"Nadel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaron","family":"Fireizen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan K.","family":"De Celie-Germana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Madera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinithi","family":"Senanayake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"2532_CR1","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","volume":"373","author":"BP O\u2019Sullivan","year":"2009","unstructured":"O\u2019Sullivan, B. P. & Freedman, S. D. Cystic fibrosis. Lancet 373, 1891\u20131904 (2009).","journal-title":"Lancet"},{"key":"2532_CR2","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1908639","volume":"381","author":"PG Middleton","year":"2019","unstructured":"Middleton, P. G. et al. Elexacaftor-Tezacaftor-Ivacaftor for cystic fibrosis with a single Phe508del Allele. N. Engl. J. Med. 381, 809\u2013819 (2019).","journal-title":"N. Engl. J. Med."},{"key":"2532_CR3","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1164\/rccm.202102-0509OC","volume":"203","author":"ET Zemanick","year":"2021","unstructured":"Zemanick, E. T. et al. A Phase 3 open-label study of Elexacaftor\/Tezacaftor\/Ivacaftor in children 6 through 11 years of age with cystic fibrosis and at least one F508 del- CFTR Allele. Am. J. Respir. Crit. Care Med. 203, 1522\u20131532 (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2532_CR4","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/sim.1104","volume":"21","author":"MD Schluchter","year":"2002","unstructured":"Schluchter, M. D., Konstan, M. W. & Davis, P. B. Jointly modeling the relationship between survival and pulmonary function in cystic fibrosis patients. Stat. Med. 21, 1271\u20131287 (2002).","journal-title":"Stat. Med."},{"key":"2532_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/ppul.21154","volume":"45","author":"HAWM Tiddens","year":"2010","unstructured":"Tiddens, H. A. W. M., Donaldson, S. H., Rosenfeld, M. & Pare, P. D. Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively? Pediatr. Pulmonol. 45, 107\u2013111 (2010).","journal-title":"Pediatr. Pulmonol."},{"key":"2532_CR6","first-page":"241","volume":"2","author":"EH Oppenheimer","year":"1975","unstructured":"Oppenheimer, E. H. & Esterly, J. R. Pathology of cystic fibrosis. Review of the literature and comparison with 146 autopsied cases. Perspect. Pediatr. Pathol. 2, 241\u2013278 (1975).","journal-title":"Perspect. Pediatr. Pathol."},{"key":"2532_CR7","first-page":"290","volume":"134","author":"RE Sobonya","year":"1986","unstructured":"Sobonya, R. E. & Taussig, L. M. Quantitative aspects of lung pathology in cystic fibrosis. Am. Rev. Respir. Dis. 134, 290\u2013295 (1986).","journal-title":"Am. Rev. Respir. Dis."},{"key":"2532_CR8","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1034\/j.1399-3003.2000.15d18.x","volume":"15","author":"HAWM Tiddens","year":"2000","unstructured":"Tiddens, H. A. W. M. et al. Cartilaginous airway wall dimensions and airway resistance in cystic fibrosis lungs. Eur. Respir. J. 15, 735\u2013742 (2000).","journal-title":"Eur. Respir. J."},{"key":"2532_CR9","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1164\/ajrccm.165.8.2104090","volume":"165","author":"R Hamutcu","year":"2002","unstructured":"Hamutcu, R. et al. Clinical findings and lung pathology in children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 165, 1172\u20131175 (2002).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2532_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/ppul.22876","volume":"49","author":"PH Quanjer","year":"2014","unstructured":"Quanjer, P. H. & Weiner, D. J. Interpretative consequences of adopting the Global Lungs 2012 Reference Equations for spirometry for children and adolescents. Pediatr. Pulmonol. 49, 118\u2013125 (2014).","journal-title":"Pediatr. Pulmonol."},{"key":"2532_CR11","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham, B. L. et al. Standardization of spirometry 2019 update. American Thoracic Society and European Respiratory Society Technical Statement. Am. J. Respir. Crit. Care Med. 200, e70\u2013e88 (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2532_CR12","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1378\/chest.123.5.1655","volume":"123","author":"ML Goris","year":"2003","unstructured":"Goris, M. L., Zhu, H. J., Blankenberg, F., Chan, F. & Robinson, T. E. An automated approach to quantitative air trapping measurements in mild cystic fibrosis. Chest 123, 1655\u20131663 (2003).","journal-title":"Chest"},{"key":"2532_CR13","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1164\/rccm.200309-1344OC","volume":"169","author":"SC Ranganathan","year":"2004","unstructured":"Ranganathan, S. C. et al. The evolution of airway function in early childhood following diagnosis of cystic fibrosis. Am. J. Respir. Crit. Care Med. 169, 928\u2013933 (2004).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2532_CR14","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1164\/rccm.200804-551OC","volume":"178","author":"BM Linnane","year":"2008","unstructured":"Linnane, B. M. et al. Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am. J. Respir. Crit. Care Med. 178, 1238\u20131244 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2532_CR15","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/ppul.22777","volume":"48","author":"EM Bakker","year":"2013","unstructured":"Bakker, E. M. et al. Small airway involvement in cystic fibrosis lung disease: routine spirometry is an early and sensitive marker. Pediatr. Pulmonol. 48, 1081\u20131088 (2013).","journal-title":"Pediatr. Pulmonol."},{"key":"2532_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1164\/ajrccm\/137.1.119","volume":"137","author":"P Hiatt","year":"1988","unstructured":"Hiatt, P., Eigen, H., Yu, P. & Tepper, R. S. Bronchodilator responsiveness in infants and young children with cystic fibrosis. Am. Rev. Respir. Dis. 137, 119\u2013122 (1988).","journal-title":"Am. Rev. Respir. Dis."},{"key":"2532_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ppul.10134","volume":"34","author":"HAWM Tiddens","year":"2002","unstructured":"Tiddens, H. A. W. M. Detecting early structural lung damage in cystic fibrosis. Pediatr. Pulmonol. Suppl. 34, 228\u2013231 (2002).","journal-title":"Pediatr. Pulmonol. Suppl."},{"key":"2532_CR18","first-page":"575","volume":"15","author":"A Zapletal","year":"1979","unstructured":"Zapletal, A., Desmond, K. J., Demizio, D. & Coates, A. L. Lung recoil and the determination of airflow abnormalities in cystic fibrosis and asthma. Physiopathol. Respir. 15, 575\u2013592 (1979).","journal-title":"Physiopathol. Respir."},{"key":"2532_CR19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/ppul.23234","volume":"50","author":"KZ Lukic","year":"2015","unstructured":"Lukic, K. Z. & Coates, A. L. Does the FEF25-75 or the FEF75 have any value in assessing lung disease in children with cystic fibrosis or asthma? Pediatr. Pulmonol. 50, 863\u2013868 (2015).","journal-title":"Pediatr. Pulmonol."},{"key":"2532_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5409\/wjcp.v8.i2.15","volume":"8","author":"A Fretzayas","year":"2019","unstructured":"Fretzayas, A., Douros, K., Moustaki, M. & Loukou, I. Applications of lung clearance index in monitoring children with cystic fibrosis. World J. Clin. Pediatr. 8, 15\u201322 (2019).","journal-title":"World J. Clin. Pediatr."},{"key":"2532_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1136\/thx.2005.045146","volume":"61","author":"PA de Jong","year":"2006","unstructured":"de Jong, P. A. et al. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 61, 80\u201385 (2006).","journal-title":"Thorax"},{"key":"2532_CR22","doi-asserted-by":"publisher","first-page":"2003380","DOI":"10.1183\/13993003.03380-2020","volume":"58","author":"S Stanojevic","year":"2021","unstructured":"Stanojevic, S. et al. Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis. Eur. Respir. J. 58, 2003380 (2021).","journal-title":"Eur. Respir. J."},{"key":"2532_CR23","doi-asserted-by":"publisher","first-page":"2002686","DOI":"10.1183\/13993003.02686-2020","volume":"58","author":"B Frauchiger","year":"2021","unstructured":"Frauchiger, B. et al. Longitudinal course of clinical lung clearance index in children with cystic fibrosis. Eur. Respir. J. 58, 2002686 (2021).","journal-title":"Eur. Respir. J."},{"key":"2532_CR24","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2214\/AJR.15.14437","volume":"206","author":"KP Murphy","year":"2016","unstructured":"Murphy, K. P., Maher, M. M. & O\u2019Conner, O. J. Imaging of cystic fibrosis and pediatric bronchiectasis. Am. J. Roentgenol. 206, 448\u2013454 (2016).","journal-title":"Am. J. Roentgenol."},{"key":"2532_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/thx.2007.077784","volume":"63","author":"PM Gustatsson","year":"2008","unstructured":"Gustatsson, P. M., DeJong, P. A., Tiddens, H. A. W. M. & Lindblad, A. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 63, 129\u2013134 (2008).","journal-title":"Thorax"},{"key":"2532_CR26","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1164\/rccm.200412-1665OC","volume":"172","author":"TM Martinez","year":"2005","unstructured":"Martinez, T. M. et al. High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 172, 1133\u20131138 (2005).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2532_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5603\/ARM.a2019.0039","volume":"87","author":"U Desai","year":"2019","unstructured":"Desai, U. & Josh, J. M. Impulse oscillometry. Adv. Respir. Med. 87, 235\u2013238 (2019).","journal-title":"Adv. Respir. Med."},{"key":"2532_CR28","first-page":"50","volume":"107","author":"AF Gelb","year":"1973","unstructured":"Gelb, A. F., Gold, W. M., Wright, R. R., Bruch, H. R. & Nadel, J. A. Physiologic diagnosis of subclinical emphysema. Am. Rev. Respir. Dis. 107, 50\u201363 (1973).","journal-title":"Am. Rev. Respir. Dis."},{"key":"2532_CR29","first-page":"124","volume":"8","author":"AF Gelb","year":"2021","unstructured":"Gelb, A. F. et al. Normal routine spirometry can mask COPD\/Emphysema in symptomatic smokers. Chronic Obstr. Pulm. Dis. 8, 124\u2013134 (2021).","journal-title":"Chronic Obstr. Pulm. Dis."},{"key":"2532_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJM197302222880805","volume":"288","author":"AF Gelb","year":"1973","unstructured":"Gelb, A. F. & Zamel, N. Simplified diagnosis of small-airway obstruction. N. Engl. J. Med. 288, 395\u2013398 (1973).","journal-title":"N. Engl. J. Med."},{"key":"2532_CR31","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.chest.2017.11.016","volume":"153","author":"AF Gelb","year":"2018","unstructured":"Gelb, A. F. et al. Further studies of unsuspected emphysema in nonsmoking patients with asthma with persistent expiratory airflow obstruction. Chest 153, 618\u2013629 (2018).","journal-title":"Chest"},{"key":"2532_CR32","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/MOP.0000000000000892","volume":"32","author":"ME Egan","year":"2020","unstructured":"Egan, M. E. Cystic fibrosis transmembrane conductor receptor modulator therapy in cystic fibrosis. Curr. Opin. Pediatr. 32, 384\u2013388 (2020).","journal-title":"Curr. Opin. Pediatr."},{"key":"2532_CR33","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jcf.2020.05.011","volume":"19","author":"N Mayer-Hamblett","year":"2020","unstructured":"Mayer-Hamblett, N. et al. Building global development strategies for CF therapeutics during a transitional CFTR modulator era. J. Cyst. Fibros. 19, 677\u2013687 (2020).","journal-title":"J. Cyst. Fibros."},{"key":"2532_CR34","doi-asserted-by":"publisher","first-page":"e0257838","DOI":"10.1371\/journal.pone.0257838","volume":"16","author":"JB O\u2019Conner","year":"2021","unstructured":"O\u2019Conner, J. B. et al. Divergence of bacterial communities in the lower airways of CF patients in early childhood. PLoS ONE 16, e0257838 (2021).","journal-title":"PLoS ONE"},{"key":"2532_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jcf.2021.02.003","volume":"20","author":"DP Nichols","year":"2021","unstructured":"Nichols, D. P. et al. PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy. J. Cyst. Fibros. 20, 205\u2013212 (2021).","journal-title":"J. Cyst. Fibros."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02532-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02532-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02532-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T16:52:14Z","timestamp":1710867134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02532-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":35,"alternative-id":["2532"],"URL":"https:\/\/doi.org\/10.1038\/s41390-023-02532-2","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"type":"print","value":"0031-3998"},{"type":"electronic","value":"1530-0447"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"14 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by Miller Children\u2019s and Women\u2019s Hospital, Long Beach Memorial Hospital, Long Beach, California, MHS IRB Number 843-18, and Cohen Children\u2019s Medical Center, Northwell Health, Lake Success, New York, IRB Number 20-0581 and Clinical Trials.gov NCT 03839992. Parents\/guardians of patients consented to inclusion of data in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}